[NBY] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[NBY] NovaBay Pharmaceuticals, Inc.
Announcement Date
15-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -230.36%
YoY- -94.84%
Quarter Report
NBY's Result
NBY's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 2,629 1,807 1,892 1,491 2,947 3,701 1,719 7.33%
PBT -111 -1,518 -1,582 -4,188 -2,150 -4,010 -5,077 -47.10%
Tax -2,271 0 -139 1 -214 1 385 -
NP -111 -1,518 -1,582 -4,189 -2,150 -4,011 -5,077 -47.10%
Tax Rate - - - - - - - -
Total Cost 2,740 3,325 3,474 5,680 5,097 7,712 6,796 -14.04%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin -4.22 -84.01 -83.62 -280.95 -72.96 -108.38 -295.35 -50.72%
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -2.71 -44.51 -69.27 -300.22 -160.53 -321.47 0.00 -
EPS Diluted -2.71 -44.51 -69.27 -300.22 -173.72 -321.47 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.